Education
About Us
Working with TipRanks
Follow Us
Giordano Christopher Thomas Insider Profile
4 Followers
Giordano Christopher Thomas, CEO, Director at Tenax Therapeutics, holds 2.60K shares in Tenax Therapeutics (Ticker: TENX). Most recently, Giordano Christopher Thomas Bought 2,605 shares of Tenax Therapeutics on Nov 20, 2025 for an estimated value of $19.98K.
Giordano Christopher Thomas has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Giordano Christopher Thomas's holdings
Insider Roles
CEO, Director
Roles that Giordano Christopher Thomas holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Giordano Christopher Thomas
Giordano Christopher Thomas's Trading History
List of latest transactions for each holding click on a transaction to see Giordano Christopher Thomas's performance on stock
You May Also Like
Giordano Christopher Thomas insider profile FAQ
What is the percentage of profitable transactions made by Giordano Christopher Thomas?
The percentage of profitable transactions made by Giordano Christopher Thomas is ―.
What is the average return per transaction made by Giordano Christopher Thomas?
The average return per transaction made by Giordano Christopher Thomas is ―.
What stocks does Giordano Christopher Thomas hold?
Giordano Christopher Thomas holds: TENX stocks.
What was Giordano Christopher Thomas’s latest transaction?
Giordano Christopher Thomas latest transaction was an Informative Buy of $19.98K.
What was Giordano Christopher Thomas's most profitable transaction?
Giordano Christopher Thomas’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Giordano Christopher Thomas's role in Tenax Therapeutics?
Giordano Christopher Thomas's role in Tenax Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.